Scientists probe fat particles to unlock heart disease secrets
NCT ID NCT00001154
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 2 times
Summary
This study looked at how fat-carrying particles called lipoproteins work in healthy people and those with high cholesterol or other lipid disorders. Researchers injected tiny, safe amounts of radioactive lipoproteins to track them in the body. The goal was to better understand how these particles contribute to hardening of the arteries.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- labeled lipoproteins or apolipoproteins
- What this could lead to
- If successful, this research could help scientists better understand how fats in the blood contribute to heart disease, potentially guiding future treatments.
- What could go wrong
- This is an observational and metabolic study, not a treatment trial. It does not test a new therapy, so direct patient benefits are unlikely.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill tame high cholesterol?
- Ancient herbal mix put to the test against high cholesterol
- Cookies that could fight cholesterol: pumpkin seeds and walnuts put to the test
- Hormone therapy may shield menopausal hearts and brains — a trial puts it to the test
- Can two experimental pills work together safely? a trial seeks answers
- Could vitamin d levels influence cholesterol in obese diabetes patients?